WESTFORD, Mass., May 15 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that its senior management will present at the 2008 Citi Investment Research Global Health Care Conference, taking place at the Hilton New York.

Cynosure's presentation will be webcast live over the Internet beginning at 2:00 p.m. (ET) Thursday, May 22, 2008. President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker plan to discuss Cynosure's business outlook, growth strategy and recent financial results. To access the live or archived webcast, visit the "Investor Relations" portion of Cynosure's website at www.cynosure.com.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com.

Contact:

Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com

SOURCE Cynosure, Inc.

CONTACT:
Scott Solomon, Vice President of Sharon Merrill Associates, Inc.
+1-617-542-5300
cyno@investorrelations.com
for Cynosure, Inc.

Web site: http://www.cynosure.com